351 related articles for article (PubMed ID: 27903537)
1. Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction.
Greulich S; Kitterer D; Latus J; Aguor E; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Mayr A; Braun N; Alscher MD; Sechtem U; Mahrholdt H
Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903537
[TBL] [Abstract][Full Text] [Related]
2. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
[TBL] [Abstract][Full Text] [Related]
3. Detection and Monitoring of Acute Myocarditis Applying Quantitative Cardiovascular Magnetic Resonance.
von Knobelsdorff-Brenkenhoff F; Schüler J; Dogangüzel S; Dieringer MA; Rudolph A; Greiser A; Kellman P; Schulz-Menger J
Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28213448
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.
Murtagh G; Laffin LJ; Beshai JF; Maffessanti F; Bonham CA; Patel AV; Yu Z; Addetia K; Mor-Avi V; Moss JD; Hogarth DK; Sweiss NJ; Lang RM; Patel AR
Circ Cardiovasc Imaging; 2016 Jan; 9(1):e003738. PubMed ID: 26763280
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Involvement in Myotonic Dystrophy Type 2 Patients With Preserved Ejection Fraction: Detection by Cardiovascular Magnetic Resonance.
Schmacht L; Traber J; Grieben U; Utz W; Dieringer MA; Kellman P; Blaszczyk E; von Knobelsdorff-Brenkenhoff F; Spuler S; Schulz-Menger J
Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27363857
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.
Liang YD; Xu YW; Li WH; Wan K; Sun JY; Lin JY; Zhang Q; Zhou XY; Chen YC
J Cardiovasc Magn Reson; 2020 Jan; 22(1):2. PubMed ID: 31902370
[TBL] [Abstract][Full Text] [Related]
7. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
8. Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.
Blaszczyk E; Grieben U; von Knobelsdorff-Brenkenhoff F; Kellman P; Schmacht L; Funk S; Spuler S; Schulz-Menger J
J Cardiovasc Magn Reson; 2019 Apr; 21(1):25. PubMed ID: 31030674
[TBL] [Abstract][Full Text] [Related]
9. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis.
Hulten E; Agarwal V; Cahill M; Cole G; Vita T; Parrish S; Bittencourt MS; Murthy VL; Kwong R; Di Carli MF; Blankstein R
Circ Cardiovasc Imaging; 2016 Sep; 9(9):e005001. PubMed ID: 27621357
[TBL] [Abstract][Full Text] [Related]
10. Regional abnormalities on cardiac magnetic resonance imaging and arrhythmic events in patients with cardiac sarcoidosis.
Okada DR; Xie E; Assis F; Smith J; Derakhshan A; Gowani Z; Ambale-Venkatesh B; Gilotra NA; Zimmerman SL; Berger RD; Calkins H; Lima JAC; Tandri H; Chrispin J
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1967-1976. PubMed ID: 31328324
[TBL] [Abstract][Full Text] [Related]
11. Cardiac magnetic resonance including parametric mapping in acute Takotsubo syndrome: Preliminary findings.
Dabir D; Luetkens J; Kuetting DLR; Feisst A; Isaak A; Schild HH; Thomas D
Eur J Radiol; 2019 Apr; 113():217-224. PubMed ID: 30927950
[TBL] [Abstract][Full Text] [Related]
12. Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis.
Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Vecchio F; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Romeo F; Braun N; Alscher MD; Sechtem U; Mahrholdt H
Eur Radiol; 2017 Nov; 27(11):4639-4649. PubMed ID: 28500368
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study.
Mayr A; Kitterer D; Latus J; Steubing H; Henes J; Vecchio F; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H; Greulich S
J Cardiovasc Magn Reson; 2016 Oct; 18(1):67. PubMed ID: 27733210
[TBL] [Abstract][Full Text] [Related]
14. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.
Ngu PJ; Butler M; Pham A; Roberts SK; Taylor AJ
Int J Cardiovasc Imaging; 2016 Apr; 32(4):629-36. PubMed ID: 26667447
[TBL] [Abstract][Full Text] [Related]
15. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular magnetic resonance detects silent heart disease missed by echocardiography in systemic lupus erythematosus.
Mavrogeni S; Koutsogeorgopoulou L; Markousis-Mavrogenis G; Bounas A; Tektonidou M; Lliossis SC; Daoussis D; Plastiras S; Karabela G; Stavropoulos E; Katsifis G; Vartela V; Kolovou G
Lupus; 2018 Apr; 27(4):564-571. PubMed ID: 28927316
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Cardiac Magnetic Resonance Strain Analysis for Detection of Cardiac Sarcoidosis.
Dabir D; Meyer D; Kuetting D; Luetkens J; Homsi R; Pizarro C; Nadal J; Thomas D
Rofo; 2018 Aug; 190(8):712-721. PubMed ID: 30045396
[TBL] [Abstract][Full Text] [Related]
18. Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus.
Puntmann VO; D'Cruz D; Smith Z; Pastor A; Choong P; Voigt T; Carr-White G; Sangle S; Schaeffter T; Nagel E
Circ Cardiovasc Imaging; 2013 Mar; 6(2):295-301. PubMed ID: 23403334
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Magnetic Resonance Mapping and Strain Assessment for the Diagnosis of Cardiac Involvement in Idiopathic Inflammatory Myopathy Patients With Preserved Left Ventricular Ejection Fraction.
Wang Y; Wang Q; Cao J; Li X; Lin L; Chen W; Wang YN; Jin ZY
J Thorac Imaging; 2021 Jul; 36(4):254-261. PubMed ID: 33560763
[TBL] [Abstract][Full Text] [Related]
20. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy.
Schelbert EB; Elkayam U; Cooper LT; Givertz MM; Alexis JD; Briller J; Felker GM; Chaparro S; Kealey A; Pisarcik J; Fett JD; McNamara DM;
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
